Progression of kidney dysfunction in the community-dwelling elderly

被引:301
作者
Hemmelgarn, B. R.
Zhang, J.
Manns, B. J.
Tonelli, M.
Larsen, E.
Ghali, W. A.
Southern, D. A.
McLaughlin, K.
Mortis, G.
Culleton, B. F.
机构
[1] Univ Calgary, Div Nephrol, Foothills Med Ctr, Dept Med, Calgary, AB T2N 2T9, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada
[3] Inst Hlth Econ, Edmonton, AB, Canada
[4] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada
[5] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada
[6] Calgary Lab Serv, Calgary, AB, Canada
[7] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB T2N 2T9, Canada
[8] Univ Calgary, Dept Med, Div Gen Internal Med, Calgary, AB T2N 2T9, Canada
关键词
anemia; albuminuria; cardiovascular disease; chronic kidney disease; epdiemiology and outcomes;
D O I
10.1038/sj.ki.5000270
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Despite the high prevalence of chronic kidney disease among the elderly, few studies have described their loss of kidney function. We sought to determine the progression of kidney dysfunction among a community-based cohort of elderly subjects. The cohort included 10 184 subjects 66 years of age or older, who had one or more outpatient serum creatinine measurements during each of two time periods: 1 July to 31 December 2001 and 1 July to 31 December 2003. A mixed effects model, including covariates for age, gender, diabetes mellitus, and comorbidity, was used to determine the rate of decline in estimated glomerular filtration rate (eGFR, in ml/min/1.73m(2)) per year over a median follow-up of 2.0 years. Subjects with diabetes mellitus had the greatest decline in eGFR of 2.1 (95% CI 1.8-2.5) and 2.7 (95% CI 2.3-3.1) ml/min/1.73m 2 per year in women and men, respectively. The rate of decline for women and men without diabetes mellitus was 0.8 (95% CI 0.6-1.0) and 1.4 (95% CI 1.2-1.6) ml/min/1.73m(2) per year. Subjects with a study mean eGFR < 30ml/min/1.73m(2), both those with and without diabetes mellitus, experienced the greatest decline in eGFR. In conclusion, we found that the majority of elderly subjects have no or minimal progression of kidney disease over 2 years. Strategies aimed at slowing progression of kidney disease should consider underlying risk factors for progression and the negligible loss of kidney function that occurs in the majority of older adults.
引用
收藏
页码:2155 / 2161
页数:7
相关论文
共 46 条
[1]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[2]   Regression to the mean: what it is and how to deal with it [J].
Barnett, AG ;
van der Pols, JC ;
Dobson, AJ .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (01) :215-220
[3]  
BJORCK S, 1991, BMJ-BRIT MED J, V304, P339
[4]   STATISTICS NOTES .1. CORRELATION, REGRESSION, AND REPEATED DATA [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1994, 308 (6933) :896-896
[5]   STATISTICS NOTES .2. REGRESSION TOWARDS THE MEAN [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1994, 308 (6942) :1499-1499
[6]   Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population [J].
Bleyer, AJ ;
Shemanski, LR ;
Burke, GL ;
Hansen, KJ ;
Appel, RG .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2072-2079
[7]   Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels [J].
Bostom, AG ;
Kronenberg, F ;
Ritz, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (08) :2140-2144
[8]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[9]  
*CAN I HLTH INF, 2001, CAN ORG REPL REG 200
[10]   Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study [J].
Chadban, SJ ;
Briganti, EM ;
Kerr, PG ;
Dunstan, DW ;
Welborn, TA ;
Zimmet, PZ ;
Atkins, RC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :S131-S138